An integrated system for the monitoring of therapy and drug's side effects in Lymphoproliferative disorders

The wide diffusion of telecommunication systems and the availability of cheap computational devices, such as smart wearable, PDA and smartphones, is multiplying the number of collaborative and remote-monitored applications accessible to a large mass of people. In particular, this scenario makes it possible the implementation of specific systems that improve the control of patients with minimal impact on the quality of their lives. This paper moves in this context and presents a general system for the continuous monitoring at home of therapy and disease symptoms. Indeed, starting from a specific application aiming at monitoring patients with Lymphoproliferative disorders and the side effects related to specific drugs used in treatment of these diseases, in this paper we present a more general framework easy customizable to the requirements of different applications. In particular, the proposed system has been designed to be easily tuned to a larger class of disorders and, in our opinion, it can be applied in almost all the scenarios where patients require a strict monitoring of their conditions in their home environment. The paper presents the model, the architecture and the implementation of the system.

[1]  Naveen Garg,et al.  Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib. , 2017, JCI insight.

[2]  B. Cheson,et al.  Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Stephan Stilgenbauer,et al.  Front-line treatment of CLL in the era of novel agents. , 2017, Cancer treatment reviews.

[4]  W. Marsden I and J , 2012 .

[5]  Ilias Sachpazidis,et al.  Image and medical data communication protocols for telemedicine and teleradiology , 2008 .

[6]  Sam Ruby,et al.  RESTful Web Services , 2007 .

[7]  C. Flowers,et al.  Clinical use of PI3K inhibitors in B-cell lymphoid malignancies: today and tomorrow , 2017, Expert review of anticancer therapy.

[8]  A Pierratos,et al.  Nocturnal hemodialysis: dialysis for the new millennium. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[9]  R. Roine,et al.  Assessing telemedicine: a systematic review of the literature. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[10]  Loredana Zollo,et al.  A modular telerehabilitation architecture for upper limb robotic therapy , 2017 .